Galectin Therapeutics (GALT)
(Delayed Data from NSDQ)
$2.65 USD
+0.02 (0.76%)
Updated Sep 26, 2024 03:59 PM ET
After-Market: $2.65 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
Earnings News For GALT
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update
-
UPDATE ? Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2023 and Provides Business Update
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2023 and Provides Business Update
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2022 and Provides Business Update